|
|
|
Volumn 313, Issue 7058, 1996, Pages 640-641
|
|
Thrombolysis in acute stroke. Defining the risk to benefit ratio for individual patients remains impossible
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALTEPLASE;
PLASMINOGEN ACTIVATOR;
BLOOD CLOT LYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
META ANALYSIS;
MORTALITY;
NEUROPROTECTION;
PRIORITY JOURNAL;
RECANALIZATION;
RISK BENEFIT ANALYSIS;
STROKE;
ACUTE DISEASE;
CEREBROVASCULAR DISORDERS;
HUMANS;
RISK FACTORS;
THROMBOLYTIC THERAPY;
|
|
EID: 0029758701
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (9)
|
|
References (0)
|
